These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25134468)
21. In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model. Sirenko O; Grimm FA; Ryan KR; Iwata Y; Chiu WA; Parham F; Wignall JA; Anson B; Cromwell EF; Behl M; Rusyn I; Tice RR Toxicol Appl Pharmacol; 2017 May; 322():60-74. PubMed ID: 28259702 [TBL] [Abstract][Full Text] [Related]
22. Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Matsui T; Miyamoto K; Yamanaka K; Okai Y; Kaushik EP; Harada K; Wagoner M; Shinozawa T Toxicol Appl Pharmacol; 2019 Nov; 383():114761. PubMed ID: 31533062 [TBL] [Abstract][Full Text] [Related]
23. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing. Maddah M; Heidmann JD; Mandegar MA; Walker CD; Bolouki S; Conklin BR; Loewke KE Stem Cell Reports; 2015 Apr; 4(4):621-31. PubMed ID: 25801505 [TBL] [Abstract][Full Text] [Related]
24. Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity. Rajasingh S; Isai DG; Samanta S; Zhou ZG; Dawn B; Kinsey WH; Czirok A; Rajasingh J Acta Pharmacol Sin; 2018 Oct; 39(10):1590-1603. PubMed ID: 29620051 [TBL] [Abstract][Full Text] [Related]
25. Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction. Stoelzle S; Haythornthwaite A; Kettenhofen R; Kolossov E; Bohlen H; George M; Brüggemann A; Fertig N J Biomol Screen; 2011 Sep; 16(8):910-6. PubMed ID: 21775699 [TBL] [Abstract][Full Text] [Related]
26. Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes / multielectrode assay platform. Lee SG; Kim J; Oh MS; Ryu B; Kang KR; Baek J; Lee JM; Choi SO; Kim CY; Chung HM Biochem Biophys Res Commun; 2021 May; 555():67-73. PubMed ID: 33813278 [TBL] [Abstract][Full Text] [Related]
39. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Yokoo N; Baba S; Kaichi S; Niwa A; Mima T; Doi H; Yamanaka S; Nakahata T; Heike T Biochem Biophys Res Commun; 2009 Sep; 387(3):482-8. PubMed ID: 19615974 [TBL] [Abstract][Full Text] [Related]
40. In vitro detection of cardiotoxins or neurotoxins affecting ion channels or pumps using beating cardiomyocytes as alternative for animal testing. Nicolas J; Hendriksen PJ; de Haan LH; Koning R; Rietjens IM; Bovee TF Toxicol In Vitro; 2015 Mar; 29(2):281-8. PubMed ID: 25479353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]